POT1 and cancer: Based on our results, we speculate that some of the telomere elongation phenotypes observed in cancer cells bearing hPOT1 OB-3 mutations might be due to enhanced telomerase recruitment to telomeres, leading to increased telomere elongation, which would endow precursor cancer cells with a proliferative advantage.